Want to know if this job is worth applying to?
San Francisco, California, United States
Remote only
Job description
CareDx is a leading precision medicine diagnostics company advancing care in transplant, specialty oncology, and cell therapy. Through our innovative portfolio of molecular diagnostics, digital health solutions, AI-powered data and analytics, and patient support services, we partner with healthcare providers, patients, and biopharma organizations to help inform clinical decision-making and improve patient outcomes.
The Medical Science Liaison (MSL) for Cell Therapy & Transplant (CTT) will collaborate directly with the Medical Director and other cross functional stakeholders to support initiation & management of a pivotal clinical study for AlloHeme, a blood based NGS relapse prediction test for post bone marrow transplant AML & MDS patients. Additionally, the MSL will be responsible for scientific exchange and advice- seeking with key opinion leaders (KOLs) in bone marrow and cell therapy transplant. Once the AlloHeme test is commercially available, the MSL will educate physicians and other key stakeholders at transplant centers about the available data and the clinical value of the AlloHeme test. In addition to AlloHeme, the MSL will be involved in establishing research collaborations and engaging with KOLs to support additional product launches including molecular testing for post cell therapy monitoring. This is an exciting opportunity to help shape CareDx’s market entry into Cell Therapy & Transplant!
The ideal candidate has experience supporting clinical studies and communicating with hematologist/oncologists KOLs. Excellent communication skills and attention to detail are essential for this role which will be remote based. Significant travel is required to attend scientific conferences, visit sites participating in research and to engage with KOLs.
Responsibilities
Qualifications
This is a remote based role with preference to those living in the west coast US. Significant travel will be required (up to 50%)
Additional Details
Every individual at CareDx has a direct impact on our collective mission to improve the lives of organ transplant patients worldwide. We believe in taking great care of our people, so they take even greater care of our patients.
Our competitive Total Rewards package for US Employees includes:
In addition, we have a Living Donor Employee Recovery Policy that allows up to 30 days of paid leave annually to a full-time employee who makes the selfless act of donating an organ or bone marrow.
With products that are making a difference in the lives of transplant patients today and a promising pipeline for the future, it’s an exciting time to be part of the CareDx team. Join us in partnering with transplant patients to transform our future together.
CareDx, Inc. is an Equal Opportunity Employer-vets/disabled, and participates in the E-Verify program. By proceeding with our application and submitting your information, you acknowledge that you have read our U.S. Personnel Privacy Notice and consent to receive email communication from CareDx. Certain jurisdictions require notice of how we use and protect your personal information. For more information, please read our Privacy Policy
The U.S. EEO posters are available here.
Note: We do not accept resumes from headhunters, placement agencies, or other suppliers that have not signed a formal agreement with us.
#LI-Remote
This is the anticipated base salary range in the United States. The final salary offered to a successful candidate will be dependent on several factors that may include, but are not limited to, the type and length of experience within the job, the type and length of experience within the industry, education, etc. Base pay is one part of the Total Package that is provided to compensate and recognize employees for their work, and this role may be eligible for additional discretionary bonuses/incentives and restricted stock units. CareDx is a multi-state employer, and this salary range may not reflect positions that work in other states.
